Srinivas Akkaraju and Samsara Biocapital, L.P. Receives Stock Award at Mineralys Therapeutics Inc (MLYS) — SEC Form 4, May 23, 2024

SEC Form 4 · No Market Transaction

Stock Award

Compensation grant — no market purchase or sale.

Reporting Owners

Srinivas Akkaraju

Director 10% Owner

Samsara Biocapital, L.P.

10%+

TXN 2024-05-22 · FILED 2024-05-23

Filing Lag 1 business day within 2-day SEC deadline

Form 4 · Statement of Changes in Beneficial Ownership

Mineralys Therapeutics Inc

MLYS CIK 0001933414

Reporting Owners

Name	Relationship
Srinivas Akkaraju CIK 0001253170	Director 10% Owner
Samsara Biocapital, L.P. CIK 0001699737	10% Owner

Srinivas Akkaraju at Mineralys Therapeutics Inc Full insider history

Bought (12 mo) —

Sold (12 mo) —

More from this insider at Mineralys Therapeutics Inc

Derivative Securities Transactions

Title	Strike	Date	Type	Shares	Price	Expiration	Underlying	Ownership
Stock OptionF1	$12.52	2024-05-22	A - Award/Grant	22,000 A	$0.00	2034-05-22	22,000 Common Stock	Direct

Footnotes (1)

F1: The stock option award vests in 12 substantially equal monthly installments beginning on June 22, 2024. In the event that the next annual meeting of stockholders occurs prior to May 22, 2025, any remaining unvested portion of the stock option award will vest on the date of such meeting. Show more

Institutional Holders

Largest by reported value

5%+ Holders · 13D/G 5 filers

Latest Schedule 13D/G per filer; stakes the filer reported closed are left out.

Other insiders at Mineralys Therapeutics Inc

GET /v1/forms/4/0001933414-24-000021 API docs